Bloomage Biotech

Bloomage Biotech (华熙生物) is a Chinese medical aesthetics and biotech company best known as a leading producer of hyaluronic acid (玻尿酸) and related skincare ingredients. Per a 2021 FreeS Research piece, it was among the first wave of Chinese "medical aesthetics stocks" to break through RMB 100 billion market cap, riding consumer demand from Gen Z buyers who ranked hyaluronic acid among their top five favored skincare ingredients . The company sits upstream in the medical aesthetics supply chain, where it has built technical moats in microbial fermentation and materials synthesis—capabilities that took years of accumulated know-how .

Beyond its core aesthetics business, Bloomage Biotech has shown up in the industrial automation and embodied AI space as an advanced manufacturing customer and strategic investor. Yifei Technology, a robotics firm that went public in Hong Kong in 2026, supplied packaging production lines to Bloomage Biotech alongside other healthcare and consumer electronics leaders . More recently, in 2025, Bloomage Biotech participated as a strategic industrial investor in Intelligent Square's (智平方) nine-figure RMB A+ round for its general-purpose embodied AI robots and GOVLA large model, with the two companies also partnering on biotech manufacturing applications .